Nokia Corporation (NOK) : The consensus on Nokia Corporation (NOK) based on 11 analyst recommendation on the company stock is 2, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Nokia Corporation (NOK) : The highest short term price target forecast on Nokia Corporation (NOK) is $8 and the lowest target price is $6. A total of 6 equity analysts are currently covering the company. The average price of all the analysts is $6.68 with a standard deviation of $0.8.
For the current week, the company shares have a recommendation consensus of Buy. Nokia Corporation (NYSE:NOK): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $5.67 and $5.67 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $5.74. The buying momentum continued till the end and the stock did not give up its gains. It closed at $5.70, notching a gain of 0.18% for the day. The total traded volume was 4,891,987 . The stock had closed at $5.69 on the previous day.
Nokia Corporation is a Finland-based telecommunication and network infrastructure company. The Company operates through two business segments: Nokia Networks and Nokia Technologies. Nokia Networks offers network infrastructure software, hardware and services, and is divided into Mobile Broadband and Global Services. Nokia Technologies develops and licenses technologies and manages an Intellectual Property (IP) portfolio of approximately 10,000 patent families consisted of approximately 30,000 individual patents and patent applications. The Company holds a majority stake in Alcatel-Lucent, among others, and owns operations and research and development (R&D) facilities in Europe, North America and Asia.